Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-10-15FDA Approved: ADALIMUMAB-ADBM — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approves a supplemental application for the adalimumab biosimilar ADALIMUMAB-ADBM from Quallent Pharmaceuticals Health LLC. The approval…
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
A completed clinical trial evaluating the impact of anti-CCP therapy for management with Enbrel in patients with psoriatic arthritis; result…
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS) [Phase 4]
Phase 4 clinical trial update evaluating Acthar in patients with psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: A Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic Arthritis [Phase 4]
Phase 4 pilot trial investigating Technetium-99m methylene diphosphonate in the treatment of psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis [Phase 2]
Phase 2 study evaluating the efficacy and safety of PF-06700841 in active psoriatic arthritis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-07-23Clinical Trial Update: SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE [Phase 4]
A Phase 4 clinical trial exploring systemic inflammation and microvascular disease prevention in psoriasis and psoriatic arthritis has been …
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis. [Phase 2]
Phase 2 trial evaluating CBD treatment for psoriatic arthritis and hand osteoarthritis has completed.
-
FDA approval · 2021-06-17FDA Approved: INFLECTRA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for INFLECTRA (infliximab-dyyb) from Pfizer Laboratories Div Pfizer Inc, marking FDA action on a bio…
-
FDA approval · 2021-06-14FDA Approved: TREXALL — Supplemental Application (Teva Women's Health, Inc.)
The FDA approved a supplemental application for TREXALL (methotrexate) filed by Teva Women's Health, Inc.
-
FDA approval · 2021-05-28FDA Approved: COSENTYX — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for COSENTYX (secukinumab) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis [Phase 2]
Phase 2 trial update on safety and tolerability of AIN457 in adults with psoriatic arthritis, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Efficacy and Safety Study of SUNPG1623 [Phase 2]
Phase 2 clinical trial update for SUNPG1623 in active psoriatic arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of BMS-986165 compared with placebo in active psoriatic arthritis; results posted.
-
CLINICAL_TRIALS withdrawal · 2021-05-13Clinical Trial Update: Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apremilast [Phase 4]
Clinical trial update notes withdrawal of a Phase 4 study evaluating PsASon ultrasound scores in patients with Psoriatic Arthritis treated w…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Psoriatic Oligoarthritis Intervention With Symptomatic thErapy [Phase 4]
Phase 4 clinical trial update on psoriatic arthritis evaluating symptomatic therapy; study completed with results posted.
-
FDA approval · 2021-03-29FDA Approved: LEFLUNOMIDE — Original Application (Aurobindo Pharma Limited)
FDA approved an original-application generic for Leflunomide from Aurobindo Pharma Limited.
-
FDA approval · 2021-02-24FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
FDA approval of a supplemental application for the adalimumab biosimilar ADALIMUMAB-ADAZ from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo [Phase 4]
Phase 4 clinical trial update evaluating secukinumab 300 mg and 150 mg versus placebo in adults with active psoriatic arthritis after 16 wee…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis [Phase 3]
Phase 3 trial comparing secukinumab to adalimumab in psoriatic arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site [Phase 3]
Phase 3 trial evaluating the efficacy and safety of secukinumab in patients with psoriatic arthritis and axial spondyloarthritis including a…
-
FDA approval · 2020-12-11FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab filed by Janssen Biotech, Inc. The action updates the product's labeling.
-
FDA approval · 2020-12-01FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approves a supplemental application for ustekinumab (Stelara) from Janssen Biotech, Inc., reflecting an approval of changes to its label…
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis [Phase 2]
Phase 2 trial update evaluating dose response, efficacy, safety, and tolerability of bimekizumab in active psoriatic arthritis; study comple…
-
CLINICAL_TRIALS trial_result · 2020-11-23Clinical Trial Update: A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL) [Phase 4]
Phase 4 trial evaluating adalimumab introduction versus methotrexate dose escalation in psoriatic arthritis; study completed with posted res…
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 trial evaluating subcutaneous guselkumab for active psoriatic arthritis has completed with posted results.